181 related articles for article (PubMed ID: 35392560)
1. Inhibitory Mechanism of Combined Hydroxychavicol With Epigallocatechin-3-Gallate Against Glioma Cancer Cell Lines: A Transcriptomic Analysis.
Abdul Rahman A; Wan Ngah WZ; Jamal R; Makpol S; Harun R; Mokhtar N
Front Pharmacol; 2022; 13():844199. PubMed ID: 35392560
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome analysis reveals the molecular mechanisms of combined gamma-tocotrienol and hydroxychavicol in preventing the proliferation of 1321N1, SW1783, and LN18 glioma cancer cells.
Abdul Rahman A; Mokhtar NM; Harun R; Jamal R; Wan Ngah WZ
J Physiol Biochem; 2019 Nov; 75(4):499-517. PubMed ID: 31414341
[TBL] [Abstract][Full Text] [Related]
3. Tocotrienol-rich fraction, [6]-gingerol and epigallocatechin gallate inhibit proliferation and induce apoptosis of glioma cancer cells.
Rahman AA; Makpol S; Jamal R; Harun R; Mokhtar N; Ngah WZ
Molecules; 2014 Sep; 19(9):14528-41. PubMed ID: 25221872
[TBL] [Abstract][Full Text] [Related]
4. Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells.
Abdul Rahman A; Jamal AR; Harun R; Mohd Mokhtar N; Wan Ngah WZ
BMC Complement Altern Med; 2014 Jul; 14():213. PubMed ID: 24980711
[TBL] [Abstract][Full Text] [Related]
5. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
[TBL] [Abstract][Full Text] [Related]
6. Green tea extract, epigallocatechin-3-gallate, inhibits the growth and invasive ability of human glioma cells.
Zhang W; Jia J
Mol Med Rep; 2008; 1(5):735-9. PubMed ID: 21479478
[TBL] [Abstract][Full Text] [Related]
7. Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines.
Kim YW; Bae SM; Lee JM; Namkoong SE; Han SJ; Lee BR; Lee IP; Kim SH; Lee YJ; Kim CK; Kim YW; Ahn WS
Cancer Res Treat; 2004 Oct; 36(5):315-23. PubMed ID: 20368822
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells.
Kwak TW; Park SB; Kim HJ; Jeong YI; Kang DH
Onco Targets Ther; 2017; 10():137-144. PubMed ID: 28053547
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth.
Bimonte S; Leongito M; Barbieri A; Del Vecchio V; Barbieri M; Albino V; Piccirillo M; Amore A; Di Giacomo R; Nasto A; Granata V; Petrillo A; Arra C; Izzo F
Infect Agent Cancer; 2015; 10():22. PubMed ID: 26225138
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of lung cancer cell lines by (-)-epigallocatechin-3-gallate in combination with clinically used nitrocatechol inhibitors of catechol-O-methyltransferase.
Forester SC; Lambert JD
Carcinogenesis; 2014 Feb; 35(2):365-72. PubMed ID: 24148818
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.
Ding YP; Gao ZL; Chen BC; Rakariyatham K; Suo HY; Tong HR; Xiao H
Nutr Cancer; 2018 Oct; 70(7):1126-1136. PubMed ID: 30513211
[TBL] [Abstract][Full Text] [Related]
15. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
Masuda M; Suzui M; Weinstein IB
Clin Cancer Res; 2001 Dec; 7(12):4220-9. PubMed ID: 11751523
[TBL] [Abstract][Full Text] [Related]
16. Effects of the Green Tea Polyphenol Epigallocatechin-3-Gallate on Glioma: A Critical Evaluation of the Literature.
Le CT; Leenders WPJ; Molenaar RJ; van Noorden CJF
Nutr Cancer; 2018 Apr; 70(3):317-333. PubMed ID: 29570984
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Liu L; Ju Y; Wang J; Zhou R
Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
[TBL] [Abstract][Full Text] [Related]
18. The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells.
Du GJ; Wang CZ; Qi LW; Zhang ZY; Calway T; He TC; Du W; Yuan CS
Phytother Res; 2013 Feb; 27(2):272-7. PubMed ID: 22566066
[TBL] [Abstract][Full Text] [Related]
19. Combined low dose ionizing radiation and green tea-derived epigallocatechin-3-gallate treatment induces human brain endothelial cells death.
McLaughlin N; Annabi B; Lachambre MP; Kim KS; Bahary JP; Moumdjian R; Béliveau R
J Neurooncol; 2006 Nov; 80(2):111-21. PubMed ID: 16715350
[TBL] [Abstract][Full Text] [Related]
20. The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.
Shervington A; Pawar V; Menon S; Thakkar D; Patel R
Mol Biol Rep; 2009 May; 36(5):1181-6. PubMed ID: 18581255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
